Asthma and the Gut Microbiome: Understanding the Gut-Lung Axis

What Is the Gut-Lung Axis?

The human gut hosts an estimated 100 trillion bacteria, fungi, and other microorganisms — collectively called the gut microbiome — that outnumber human cells in the body. For decades, researchers assumed the gut microbiome mattered only for digestion. It is now clear that gut bacteria communicate constantly with the immune system, and — through shared immune cells, circulating metabolites, and lymphatic connections — with the lungs as well. This bidirectional communication is called the gut-lung axis.

In practical terms: the bacteria living in your intestines help determine how your immune system responds to allergens and irritants that reach your airways. An imbalanced gut microbiome — a state called dysbiosis — is increasingly linked to allergic sensitization, bronchial hyperreactivity, and asthma severity, particularly in children.

The Hygiene Hypothesis: Where the Idea Began

In 1989, epidemiologist David Strachan observed that children with more older siblings had lower rates of hay fever, and proposed that early childhood infections transmitted by unhygienic contact with older siblings might protect against allergic disease later in life. This became known as the hygiene hypothesis. The modern, refined version focuses less on infections specifically and more on microbial diversity: children raised in environments with rich and varied microbial exposure — farms, larger families, pets, unpasteurized dairy in some populations — develop more balanced immune regulation and lower rates of asthma and allergy.

The clearest evidence comes from studies comparing Amish and Hutterite communities in the United States — genetically similar populations with very different farming practices. Amish children, who have extensive contact with traditional dairy farm environments from infancy, have dramatically lower asthma and allergy rates than Hutterite children, who use industrialized farming with far less direct animal and microbial exposure. Researchers traced part of this protective effect to compounds in barn dust that shape early immune development, working in concert with a more diverse gut microbiome.

Early-Life Windows: When the Microbiome Shapes Immune Development

The first 1,000 days of life — from conception through age two — represent a critical window during which the gut microbiome matures and calibrates the developing immune system. Several early-life exposures during this window are consistently associated with later asthma risk:

Mode of Delivery

Infants born vaginally are seeded with maternal vaginal and gut bacteria during birth, producing an early microbiome dominated by Lactobacillus and Bacteroides species. Infants born by cesarean section instead acquire bacteria primarily from skin contact and the hospital environment, resulting in a different, often less diverse, initial microbiome. Multiple large cohort studies associate C-section delivery with a modestly increased risk of childhood asthma — on the order of 20–30% relative risk increase in meta-analyses — though the effect is one of many contributing factors, and C-sections remain medically necessary and life-saving in many circumstances.

Antibiotic Exposure in Infancy

Antibiotics are sometimes essential in infancy, but they act as a blunt instrument on the developing gut microbiome, reducing bacterial diversity and eliminating beneficial species alongside harmful ones. Observational studies, including large Scandinavian birth-cohort data, associate antibiotic courses in the first year of life — particularly broad-spectrum antibiotics and repeated courses — with increased risk of later childhood asthma and wheeze. This does not mean antibiotics should be withheld when medically indicated; it supports judicious, evidence-based prescribing in infants.

Breastfeeding Versus Formula Feeding

Breast milk contains human milk oligosaccharides (HMOs) — complex sugars that infants cannot digest directly but that selectively feed beneficial gut bacteria, particularly Bifidobacterium species. This creates a microbiome enriched in organisms that produce protective metabolites. Formula-fed infants tend to have a more adult-like, diverse microbiome earlier, lacking some of this HMO-driven selective enrichment. Multiple studies associate exclusive breastfeeding for at least four to six months with modestly reduced asthma and wheeze risk, an effect partly attributed to microbiome differences.

Household Pets and Sibling Exposure

Consistent with the hygiene hypothesis, early exposure to dogs in the household and having older siblings are both associated with lower rates of childhood asthma in multiple studies, plausibly through increased microbial diversity in the home environment during infancy.

Short-Chain Fatty Acids: The Gut-Lung Messenger Molecules

One of the clearest mechanistic links in the gut-lung axis involves short-chain fatty acids (SCFAs) — butyrate, propionate, and acetate — produced when gut bacteria, particularly members of the phylum Firmicutes, ferment dietary fiber that would otherwise pass through undigested.

SCFAs enter the bloodstream and travel throughout the body, where they:

• Promote regulatory T cells (Tregs): These immune cells dampen excessive allergic and inflammatory responses. Butyrate in particular promotes Treg differentiation in the gut and at distant sites, including the lungs.
• Reduce dendritic cell activation: Dendritic cells present allergens to the immune system. SCFAs modulate this presentation process to favor tolerance over allergic sensitization.
• Support epithelial barrier integrity: Butyrate is the primary fuel source for cells lining the gut, and healthier gut barriers reduce systemic inflammatory signaling that can reach the lungs.

A widely cited 2019 study in Nature Communications found that infants with lower fecal SCFA levels, particularly butyrate and propionate at age one, had significantly higher rates of allergic sensitization and asthma by age six. This finding, along with animal studies showing that SCFA supplementation reduces allergic airway inflammation in mouse models, has made SCFA production a central focus of gut-lung axis research.

The Bacteroidetes-to-Firmicutes ratio and overall bacterial diversity — often summarized by measures like the Shannon diversity index in research studies — are commonly reported markers of a "healthy" microbiome profile, though clinical interpretation of individual test results remains an active area of research rather than routine practice.

Dysbiosis in Established Asthma

Beyond early-life risk, gut dysbiosis has also been observed in children and adults with established asthma, characterized by reduced overall bacterial diversity and shifts away from SCFA-producing genera such as Faecalibacterium, Bifidobacterium, and Akkermansia. Some research also points to a parallel "airway microbiome" — bacteria living in the lungs themselves, once considered sterile — that shows altered composition in asthma, with increased presence of Proteobacteria and reduced Bacteroidetes in some studies, particularly in more severe or steroid-resistant asthma phenotypes.

It is important to be clear about what this evidence does and does not show: dysbiosis is associated with asthma, and biologically plausible mechanisms exist to explain the relationship, but dysbiosis is not the same as having asthma, does not by itself cause asthma in every case, and correcting it is not a proven cure. Genetics, allergen exposure, air quality, and other established risk factors continue to matter alongside microbiome status.

Do Probiotics Help With Asthma? What the Trials Show

Given the SCFA and Treg mechanisms described above, probiotic supplementation is a natural area of research interest. Results to date are mixed:

• Several trials of specific Lactobacillus rhamnosus and Bifidobacterium strains given to pregnant women and infants show modest reductions in eczema and, in some studies, wheeze episodes — though effects on formally diagnosed asthma are less consistent.
• A 2022 systematic review and meta-analysis in pediatric populations found a small but statistically significant reduction in asthma exacerbation frequency with certain probiotic strains, alongside substantial heterogeneity between studies in strain, dose, and duration.
• Trials in adults with established asthma have generally shown weaker or inconsistent effects compared with pediatric prevention-focused studies.

The takeaway for patients: probiotics are not currently recommended by major asthma guidelines (GINA, NAEPP) as a treatment for asthma, and they are not a substitute for inhaled corticosteroids, biologics, or other physician-prescribed therapy. Interest in specific strains for specific populations — particularly infants at high allergy risk — is an active and evolving research area worth discussing with your physician or pediatrician.

Practical, Physician-Guided Strategies to Support Gut Health

While microbiome-targeted asthma therapy is not yet standard of care, several general strategies with strong independent evidence for gut health may plausibly support the gut-lung axis as part of a comprehensive approach — always discussed with your physician:

1. Prioritize dietary fiber: Fiber from vegetables, fruits, legumes, and whole grains is the primary fuel for SCFA-producing gut bacteria. Most American adults consume well below the recommended 25–38 g/day.
2. Increase dietary diversity: A wider variety of plant foods supports a more diverse gut microbiome than a narrow, repetitive diet, independent of total fiber amount.
3. Include fermented foods: Yogurt with live cultures, kefir, and fermented vegetables provide live bacteria and may support microbiome diversity, though effects vary by product and individual.
4. Limit unnecessary antibiotic use: Reserve antibiotics for physician-confirmed bacterial infections, particularly in infants and young children, to preserve microbiome diversity during critical developmental windows.
5. Support breastfeeding when possible: For families with infants, breastfeeding for at least four to six months, when feasible, is associated with multiple respiratory and immune benefits.
6. Discuss probiotics with your physician: Rather than self-selecting a probiotic product, ask your physician or pediatrician whether a specific, evidence-supported strain is appropriate for your situation.

These strategies complement, rather than replace, standard asthma management such as inhaled corticosteroids and, for eligible patients, biologic therapy for severe asthma. Nutrition and gut health are supportive factors in a broader treatment plan, not standalone cures.

This gut-focused, whole-diet approach pairs naturally with other nutrition-focused asthma strategies Dr. Hull discusses with patients, including adequate dietary antioxidants, sufficient vitamin D, and adequate dietary magnesium — together forming a nutrient-dense dietary pattern associated with better airway outcomes across multiple independent lines of research.

South Florida-Specific Considerations

Several factors specific to life in Broward County are worth considering in the context of gut and airway health:

• Year-round produce access: South Florida's growing season allows access to fresh, fiber-rich produce nearly year-round — an advantage for building a fiber-diverse diet compared with regions with shorter growing seasons.
• Humidity and mold exposure: South Florida's humidity supports indoor mold growth, which interacts with airway inflammation independent of gut factors. Addressing home moisture control remains important regardless of dietary strategy.
• Antibiotic stewardship in pediatric practices: Families should feel comfortable asking their pediatrician whether an antibiotic is necessary for a given illness, particularly for infants, to help preserve early-life microbiome diversity.
• Processed and fast-food availability: Convenience-food-heavy diets common in many South Florida households tend to be low in fiber. Small, sustainable substitutions — beans instead of rice sides, whole fruit instead of juice — can meaningfully increase fiber intake over time.

What This Means for Your Asthma Action Plan

The gut-lung axis is one of the most active areas of asthma research, and the science continues to evolve quickly. For patients and families, the practical message is measured optimism: gut health is a legitimate, biologically plausible contributor to asthma risk and severity, dietary fiber and diversity are reasonable, low-risk strategies with independent health benefits beyond asthma, and probiotics may have a role for specific patients but are not a proven asthma treatment on their own.

None of this replaces guideline-based asthma management. If your or your child's asthma is not well controlled, the priority remains an accurate diagnosis, appropriate controller therapy, and trigger management — with nutrition and gut health considered as a supportive part of the overall picture.

Frequently Asked Questions

When to Call Dr. Hull

If your or your child's asthma remains poorly controlled, or if you have questions about how nutrition and gut health fit into a broader asthma management plan, Dr. Frank Hull brings more than 20 years of pulmonary research experience to an evidence-based, individualized approach at our Plantation, FL clinic.

Schedule a consultation today to discuss a comprehensive asthma action plan. Always consult your physician before changing your medication regimen or starting new supplements.

Related Articles

• Antioxidants and Asthma: Oxidative Stress, Diet, and Lung Health
• Magnesium and Asthma: What Every Patient Needs to Know
• Vitamin D and Asthma: What the Research Shows
• Biologic Therapy for Severe Asthma
• Inhaled Corticosteroids: The Foundation of Asthma Control
• Understanding Different Types of Asthma
• Oral Steroids and Asthma: Benefits, Risks, and Alternatives
• Eosinophil Count and Asthma Severity
• Exercise-Induced Bronchoconstriction: Causes, Diagnosis, and Treatment
• Lung Function Testing Explained